In 2019-20 nine indicators were retired LDOB005; LDOB007; LDOB008; LDOB0053; LDOB0054; LDOB0073; LDOB0074; LDOB0075 and LDOB0076. They related to Health Checks, BMI assessments, Diabetes Mellitus and Angina.
Sixteen new indicators were introduced LDOB077; LDOB078; LDOB079; LDOB080; LDOB081; LDOB082; LDOB083; LDOB084; LDOB085; LDOB086; LDOB087; LDOB088; LDOB089; LDOB090; LDOB091; LDOB092. These relate to Autism, Health Checks, Antipsychotic prescribing, Benzodiazepine prescribing, prescribing of epilepsy drugs, Antidepressant prescribing and Attention Deficit Hyperactivity Disorder (ADHD).
Fourteen of the new indicators were introduced to monitor the prescription of medication to patients with a learning disability to support the NHS STOMP (stopping over medication of people with a learning disability, autism, or both) campaign.
“Research studies using general practice data in the Clinical Practice Research Datalink indicate that prevalence of use of antipsychotic and antidepressant drugs in adults with learning disabilities around 17% (Glover et al, 2015). This is substantially more than the levels appropriate to treatment of mental health problems and is thought to arise from clinically inappropriate approaches to managing behaviour.”
LDOB005 has been superseded by LDOB079 and LDOB080 and are not comparable due to a change in the definition and introduction of age criteria, to align these indicators with the Quality and Outcomes Framework (QOF) data.
More information on the indicators can be found in the Business Rules.
Data for the years 2015-16, 2016-17, 2017-18, 2018-19 and 2019-20 has been extracted in October 2020 to take account of changes in the indicators.
Year on year comparisons with 2015-16, 2016-17, 2017-18, 2018-19 and 2019-20 data shows minor variations within individual indicators. A small number of indicators show greater variation across the time series and are highlighted in the accompanying webpage. It is important to note that some differences may be due to changes in practice participation or how data is recorded within practices, but it is not possible to say how much variation is due to this.
This publication does not include sections on 'Life Expectancy' and 'Mortality' due to issues in obtaining mortality data. Analysis on the excess mortality indicator and life expectancy comparisons will be published at a future date when the data becomes available.